Literature DB >> 1511425

In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors.

P Laccetti1, G Portella, M R Mastronicola, A Russo, R Piccoli, G D'Alessio, G Vecchio.   

Abstract

We investigated the antitumoral effect of bovine seminal RNase (BS-RNase) in vivo and in vitro on a model system of epithelial tumor- and metastasis-derived cells as well as on epithelial tumors derived from the same system. We found that while BS-RNase significantly inhibited the growth in vitro of the epithelial tumor-derived cells, its inhibitory effect was even more dramatic on the growth of metastasis-derived cells. BS-RNase exerted no appreciable growth inhibition on normal thyroid epithelial cells. When administered in vivo to rats bearing solid carcinomas, having the same thyroid origin, BS-RNase induced a drastic reduction in the tumor weight, with no detectable toxic effects on the treated animals. These data show, for the first time on a system of neoplastically transformed epithelial cells, that BS-RNase has a potent specific antitumoral activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511425

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.

Authors:  R Piccoli; S Di Gaetano; C De Lorenzo; M Grauso; C Monaco; D Spalletti-Cernia; P Laccetti; J Cinátl; J Matousek; G D'Alessio
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation.

Authors:  Esther Carreras; Ester Boix; Susanna Navarro; Helene F Rosenberg; Claudi M Cuchillo; M Victòria Nogués
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Hints on the evolutionary design of a dimeric RNase with special bioactions.

Authors:  A Di Donato; V Cafaro; I Romeo; G D'Alessio
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

4.  Molecular cloning and characterization of a novel human ribonuclease (RNase k6): increasing diversity in the enlarging ribonuclease gene family.

Authors:  H F Rosenberg; K D Dyer
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

5.  Molecular evolution of genes encoding ribonucleases in ruminant species.

Authors:  E Confalone; J J Beintema; M P Sasso; A Carsana; M Palmieri; M T Vento; A Furia
Journal:  J Mol Evol       Date:  1995-12       Impact factor: 2.395

6.  Catalytic activity of bovine seminal ribonuclease is essential for its immunosuppressive and other biological activities.

Authors:  J S Kim; J Soucek; J Matousek; R T Raines
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

7.  Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.

Authors:  M P Deonarain; A A Epenetos
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

Review 8.  Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Authors:  Giovanni Gotte; Marta Menegazzi
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

Review 9.  Targeting enzymes for cancer therapy: old enzymes in new roles.

Authors:  M P Deonarain; A A Epenetos
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin.

Authors:  D Spalletti-Cernia; R Sorrentino; S Di Gaetano; R Piccoli; M Santoro; G D'Alessio; P Laccetti; G Vecchio
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.